profit from every $100 of sales.
$0$100
Anteris Technologies Global
$5.94+4.39% today
+52.7% in 1 year
1-year low $3.381-year high $10.57
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2021 to 2023.
0%20% a year
It has no yearly profit to compare the price with.
CheapExpensive
It holds more cash than debt.
No debt5 years
Money in, money out
What Anteris Technologies Global sold, what it kept, and what it did with the cash.
Sales went from $5.83 million in 2021 to $2.73 million in 2023, with -$46.0 million of profit last year.
SalesProfit
Anteris Technologies Global vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Anteris Technologies Global | No profit yet | ||
 Boston Scientific | 22.0× · Fair price | ||
 Koninklijke Philips | 30.0× · Fair price | ||
 Steris | 31.9× · Expensive | ||
 Zimmer Biomet Holdings | 29.1× · Fair price |
AI analysis
An AI analyst reads Anteris Technologies Global's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2021 | 2022 | 2023 |
|---|---|---|---|
| 6 | 3 | 3 | |
| 2 | 0 | 1 | |
| -16 | -31 | -47 | |
| -15 | -29 | -46 | |
| -17 | -31 | -46 | |
| – | -2.26 | -2.94 | |
| 32.7% | 9.3% | 32.1% | |
| -279.9% | -983.8% | -1,706.0% | |
| -294.5% | -954.9% | -1,682.8% |
Balance sheet
| In millions of USD | 2021 | 2022 | 2023 |
|---|---|---|---|
| Total assets | 21 | 16 | 31 |
| Cash | 15 | 9 | 21 |
| Total debt | 4 | 1 | 2 |
| Total liabilities | 11 | 7 | 12 |
| 11 | 9 | 19 | |
| – | 13 | 16 | |
| -87.0% | -236.7% | -175.7% | |
| -163.1% | -338.3% | -238.4% |
Cash flow
| In millions of USD | 2021 | 2022 | 2023 |
|---|---|---|---|
| -14 | -29 | -35 | |
| 1 | 2 | 2 | |
| -15 | -31 | -37 | |
| Dividends paid | – | – | – |
| – | – | – | |
| 0 | 3 | 6 |
Valuation
- –
- –
- –
- 0.7×
- 211.4×
- –
- –
- -6.4%
- -8.0%
- 0.0%
Profitability
- 32.1%
- -1,706.0%
- -1,682.8%
- -5,097.9%
- -34.0%
- -1,012.6%
- -124.4%
- -32.3%
- -34.2%
- 3,788.3%
Growth
- −31.5%
- –
- −25.6%
- –
- −10.0%
Financial health
- -0.4×
- 0.01
- 1.3%
- -1,298.9×
- 20.93
- 20.93
- 0.01
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 15%of 948
Bottom 3%of 868
Bottom 16%of 985
What analysts expect
- Average price target
- $15.00
- Range
- $15.00 – $15.00
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| May 12, 2026 | -0.28 | -0.27 | −3.4% |
| Feb 26, 2026 | -0.75 | -0.50 | −49.0% |
| Nov 12, 2025 | -0.62 | -0.56 | −10.7% |
| Aug 11, 2025 | -0.58 | -0.50 | −16.0% |
| May 13, 2025 | -0.61 | -0.45 | −35.6% |
| Apr 29, 2025 | -0.82 | – | – |
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
1/7Passes 1 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
37No pass
Benjamin Graham
70Pass
Philip Fisher
42No pass
Peter Lynch
40No pass
Joel Greenblatt
0No pass
Charlie Munger
46No pass
Terry Smith
35No pass
Questions about Anteris Technologies Global
Is Anteris Technologies Global a good stock to buy?
A business with weak numbers that is not profitable yet. 1 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Anteris Technologies Global AI analysis
What does Anteris Technologies Global do?
Anteris Technologies Global Corp., a structural heart company, discovers, develops, and commercializes medical devices to enhance the quality of life for patients with aortic stenosis. It is in Medical - Devices.
Does Anteris Technologies Global pay a dividend?
No. Anteris Technologies Global does not pay a dividend at the moment.
Is Anteris Technologies Global stock halal?
Yes. Anteris Technologies Global passes our halal screen: its business is permitted and its debt is 0.3% of its market value, under the 30% limit. How we check
How has Anteris Technologies Global stock done over the past year?
Up 52.7% over the past twelve months, to $5.94. It traded between $3.38 and $10.57 and is 43.8% below its high.
Who are Anteris Technologies Global's competitors?
The largest listed companies in the same industry are Boston Scientific, Koninklijke Philips, Steris and Zimmer Biomet Holdings. The peers table on this page compares their profit, growth and price with Anteris Technologies Global's.
Prices: daily closes to Nov 9, 2026. Fundamentals: company reports via invest-like data.